Partially autonomous AI screening for mammography safely increases cancer detection while reducing radiologist workload.
Key Details
- 1Prospective study included 31,301 women (2022-2024) undergoing routine mammograms.
- 2AI approach excluded low-risk cases from radiologist review, leading to 63.6% overall workload reduction.
- 3Cancer detection rate increased from 6.3 to 7.3 per 1,000 women; recall rate rose from 4.8% to 5.5%.
- 4Positive predictive value was maintained despite excluding two-thirds of exams from radiologist reading.
- 5Workload dropped by 62.1% for digital mammography and 65.5% for digital breast tomosynthesis (DBT).
- 6Researchers noted the need for further studies on legal, safety, and ethical aspects of AI triage.
Why It Matters
This study demonstrates the feasibility of AI to streamline breast cancer screening workflows while improving detection rates, raising important considerations for clinical implementation, regulation, and ethics in radiology-AI integration.
Source
AuntMinnie
Related News
•Radiology Business
New AI Flags Uncertainty in Breast Cancer Imaging Predictions
University of Pittsburgh researchers developed an AI model that quantifies uncertainty in breast cancer diagnostic predictions to enhance trustworthiness.
•Radiology Business
Webinar to Showcase Successful AI Automation in Radiology Workflows
A webinar will provide insights from imaging leaders on expanding and optimizing AI-driven automation in radiology clinical workflows.
•Radiology Business
Everlywell Launches Direct-to-Consumer Mammography AI for Breast Cancer Risk
Everlywell now offers the FDA-authorized Clairity Breast AI tool for patients to assess breast cancer risk from their mammograms.